Citrasate is an acid concentrate used for bicarbonate based dialysis that utilises Citric Acid.

Advanced Renal Technologies Inc. WA. USA (ART) developed a new haemodialysis concentrate formulation that better addresses patients individual needs and brings HD treatment to a more effective level, and now marketed throughout the UK and Eire by Health Tec Medical Ltd.

Containing Citric Acid as the main acidifying agent Citrasate® is the first major change in dialysate formulation in over 30 years, breaking away from traditional formulations that contain acetic acid.

It is manufactured for us under licence by MTN in Germany and CE certified as a Medical Device for all haemodialysis/haemofiltration patients both chronic and acute and is already well established on the UK market and is in use extensively at several major dialysis units including Freeman Hospital Newcastle,St.James Hospital Leeds (and satellites),Royal Sunderland Hospital, New Cross Hospital Wolverhampton,Southmead Hospital Bristol (and satellites),The Royal Free London and Dorset County Hospital

About MTN - our contracted supplier

Enquire about this product

Citrasate formulations

Users manual

Citrasate - the clinical benefits

Available in a wide variety of different formulations as shown above in either 5L or 6L cans.

  • Represents first major change in dialysate chemical composition in 30 years